DOJ awards $12.9M for Influenza Vaccines for Inmates, 2026-2027 Season
Contract Overview
Contract Amount: $12,889 ($12.9K)
Contractor: Sanofi Vaccines US Inc.
Awarding Agency: Department of Justice
Start Date: 2026-03-17
End Date: 2026-09-30
Contract Duration: 197 days
Daily Burn Rate: $65/day
Competition Type: FULL AND OPEN COMPETITION
Pricing Type: FIRM FIXED PRICE
Sector: Healthcare
Official Description: INFLUENZA VIRUS VACCINES FOR INMATES 2026- 2027 SEASON CONTRACT #- 36E79726D0009
Place of Performance
Location: SWIFTWATER, MONROE County, PENNSYLVANIA, 18370
Plain-Language Summary
Department of Justice obligated $12,889.2 to SANOFI VACCINES US INC. for work described as: INFLUENZA VIRUS VACCINES FOR INMATES 2026- 2027 SEASON CONTRACT #- 36E79726D0009 Key points: 1. Contract awarded to Sanofi Vaccines US Inc. for essential inmate healthcare. 2. Full and open competition was utilized, suggesting a competitive bidding process. 3. The contract value is relatively modest for pharmaceutical supplies. 4. Focus on seasonal influenza vaccination addresses public health within correctional facilities.
Value Assessment
Rating: good
The contract value of $12.9M for influenza vaccines appears reasonable for the specified quantity and season. Benchmarking against similar federal contracts for mass vaccination programs would provide a more precise assessment.
Cost Per Unit: N/A
Competition Analysis
Competition Level: full-and-open
The contract was awarded under full and open competition, indicating that multiple vendors had the opportunity to bid. This method generally promotes competitive pricing and ensures the government receives fair market value.
Taxpayer Impact: Taxpayer funds are used efficiently through a competitive process to procure necessary seasonal vaccines, ensuring inmate health and potentially reducing broader outbreaks.
Public Impact
Ensures health and safety of federal inmates during the 2026-2027 influenza season. Contributes to public health by preventing disease spread within correctional facilities. Supports the pharmaceutical manufacturing sector through government procurement.
Waste & Efficiency Indicators
Waste Risk Score: 65 / 10
Warning Flags
- Potential for price fluctuations in future seasons.
- Dependence on a single supplier for a critical health commodity.
Positive Signals
- Proactive health measure for a vulnerable population.
- Competitive bidding process likely secured favorable pricing.
- Ensures continuity of care for inmates.
Sector Analysis
This contract falls within the Pharmaceutical Preparation Manufacturing sector. Federal spending in this area is crucial for public health initiatives, including vaccination programs for various populations. Benchmarks for similar vaccine procurements would indicate if this award is within the expected range.
Small Business Impact
The data does not indicate any specific set-asides for small businesses. The primary awardee, Sanofi Vaccines US Inc., is a large pharmaceutical company, suggesting limited direct opportunity for small businesses in this particular contract.
Oversight & Accountability
The contract is managed by the Department of Justice, Federal Prison System / Bureau of Prisons. Oversight would involve monitoring delivery, quality, and adherence to contract terms to ensure accountability and effective use of funds.
Related Government Programs
- Pharmaceutical Preparation Manufacturing
- Department of Justice Contracting
- Federal Prison System / Bureau of Prisons Programs
Risk Flags
- Supply chain disruptions impacting vaccine availability.
- Potential for adverse reactions or lower-than-expected vaccine efficacy.
- Budgetary constraints in future fiscal years impacting procurement.
- Changes in influenza strains requiring updated vaccine formulations.
Tags
pharmaceutical-preparation-manufacturing, department-of-justice, pa, delivery-order, under-100k
Frequently Asked Questions
What is this federal contract paying for?
Department of Justice awarded $12,889.2 to SANOFI VACCINES US INC.. INFLUENZA VIRUS VACCINES FOR INMATES 2026- 2027 SEASON CONTRACT #- 36E79726D0009
Who is the contractor on this award?
The obligated recipient is SANOFI VACCINES US INC..
Which agency awarded this contract?
Awarding agency: Department of Justice (Federal Prison System / Bureau of Prisons).
What is the total obligated amount?
The obligated amount is $12,889.2.
What is the period of performance?
Start: 2026-03-17. End: 2026-09-30.
What is the historical pricing trend for influenza vaccines procured by the Federal Prison System?
Analyzing historical pricing data for influenza vaccines procured by the Federal Prison System is crucial for assessing value. Understanding past price points, considering inflation and market dynamics, allows for a more informed evaluation of the current $12.9M award. This historical context helps determine if the current price represents a fair market value or if there are opportunities for cost savings in future procurements.
What are the contingency plans if Sanofi Vaccines US Inc. fails to meet delivery or quality standards?
Contingency plans for supplier failure are vital for ensuring continuity of care. The contract should outline remedies for non-performance, such as penalties or the right to procure from alternative sources. The government's ability to quickly secure alternative supplies or enforce contract terms mitigates the risk of vaccine shortages impacting inmate health and facility operations.
How does the effectiveness of this specific influenza vaccine compare to other available options for the target population?
Evaluating the effectiveness of the chosen influenza vaccine against available alternatives is key to maximizing public health impact. Factors like strain coverage, efficacy rates in similar demographics, and potential side effects should be considered. Ensuring the selected vaccine offers the best protection for the inmate population, given the specific strains anticipated for the season, optimizes the return on this public health investment.
Industry Classification
NAICS: Manufacturing › Pharmaceutical and Medicine Manufacturing › Pharmaceutical Preparation Manufacturing
Product/Service Code: MEDICAL/DENTAL/VETERINARY EQPT/SUPP
Competition & Pricing
Extent Competed: FULL AND OPEN COMPETITION
Solicitation Procedures: NEGOTIATED PROPOSAL/QUOTE
Pricing Type: FIRM FIXED PRICE (J)
Evaluated Preference: NONE
Contractor Details
Parent Company: Sanofi
Address: 1 DISCOVERY DR, SWIFTWATER, PA, 18370
Business Categories: Category Business, Corporate Entity Not Tax Exempt, Foreign Owned, Foreign-Owned and U.S.-Incorporated Business, Manufacturer of Goods, Not Designated a Small Business, Special Designations
Financial Breakdown
Contract Ceiling: $12,889
Exercised Options: $12,889
Current Obligation: $12,889
Contract Characteristics
Commercial Item: COMMERCIAL PRODUCTS/SERVICES
Cost or Pricing Data: NO
Parent Contract
Parent Award PIID: 36E79726D0009
IDV Type: IDC
Timeline
Start Date: 2026-03-17
Current End Date: 2026-09-30
Potential End Date: 2026-09-30 00:00:00
Last Modified: 2026-04-02
More Contracts from Sanofi Vaccines US Inc.
- 00hcvgbc-2009-68767 - Sanofi VFC Pediatric Vaccine Contract — $737.3M (Department of Health and Human Services)
- Vaccince for Children 2010 — $709.2M (Department of Health and Human Services)
- Vaccine for Children 2011 — $640.0M (Department of Health and Human Services)
- Vacccine for Children 2008 Contract — $590.5M (Department of Health and Human Services)
- VFC 2012 — $589.8M (Department of Health and Human Services)
Other Department of Justice Contracts
- Contractor Owned and Operated Existing Correctional Facility for Approximately 3,500 LOW Security Male Inmates — $794.5M (Cornell Companies, Inc.)
- Detention Services - SAN Diego — $776.9M (THE GEO Group, Inc.)
- CO: Telly Renfroe Award of NEW Task Order Base Year Initial Funding — $616.4M (AT&T Enterprises, LLC)
- TAS 151060 - Services for the Management and Operation of a Contractor-Owned, Contractor-Operated, Correctional Facility for 2,567 Beds in Adams County, Mississippi — $574.3M (Corecivic, Inc.)
- Provide Services for the Management and Operation of a Correctional Facility in Accordance With Rfp-Pcc-0014 — $568.9M (Cornell Companies, Inc.)